Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization.

Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Mitsuhide N, Deinum J, Schultzekool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller P, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Chang CC, Wu VC, Somloova Z, Maiolino G, Barbiero G, Battistel M, Lenzini L, Quaia E, Pessina AC, Rossi GP.

J Clin Endocrinol Metab. 2019 Sep 20. pii: dgz017. doi: 10.1210/clinem/dgz017. [Epub ahead of print]

PMID:
31536622
2.

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70.

Königshausen E, Potthoff SA, Woznowski M, Stegbauer J, Rump LC, Sellin L.

J Vis Exp. 2019 Aug 9;(150). doi: 10.3791/59064.

PMID:
31449238
3.

[Renal cortical necrosis after application of tranexamic acid in peripartal hemorrhage].

Hoch H, Stegbauer J, Wiech T, Barwing J, Karbowski B, Fehm T, Rump LC.

Dtsch Med Wochenschr. 2019 May;144(10):678-682. doi: 10.1055/a-0857-8606. Epub 2019 May 13. German.

PMID:
31083737
4.

Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation.

Tillmann FP, Quack I, Woznowski M, Rump LC.

PLoS One. 2019 Mar 29;14(3):e0214048. doi: 10.1371/journal.pone.0214048. eCollection 2019.

5.

Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.

Stegbauer J, Thatcher SE, Yang G, Bottermann K, Rump LC, Daugherty A, Cassis LA.

J Vasc Surg. 2019 Mar 5. pii: S0741-5214(19)30127-2. doi: 10.1016/j.jvs.2018.11.045. [Epub ahead of print]

PMID:
30850299
6.

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins.

Königshausen E, Potthoff SA, Haase R, Meyer-Schwesinger C, Kaufmann E, Rump LC, Stegbauer J, Sellin L, Quack I, Woznowski M.

J Vis Exp. 2019 Jan 18;(143). doi: 10.3791/58542.

PMID:
30735184
7.

Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.

Bartolomaeus H, Balogh A, Yakoub M, Homann S, Markó L, Höges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, Haase N, Kräker K, Hering L, Maase M, Kusche-Vihrog K, Grandoch M, Fielitz J, Kempa S, Gollasch M, Zhumadilov Z, Kozhakhmetov S, Kushugulova A, Eckardt KU, Dechend R, Rump LC, Forslund SK, Müller DN, Stegbauer J, Wilck N.

Circulation. 2019 Mar 12;139(11):1407-1421. doi: 10.1161/CIRCULATIONAHA.118.036652.

8.

Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Meyer LS, Wang X, Sušnik E, Burrello J, Burrello A, Castellano I, Eisenhofer G, Fallo F, Kline GA, Knösel T, Kocjan T, Lenders JWM, Mulatero P, Naruse M, Nishikawa T, Peitzsch M, Rump LC, Beuschlein F, Hahner S, Gomez-Sanchez CE, Reincke M, Williams TA.

Hypertension. 2018 Sep;72(3):650-657. doi: 10.1161/HYPERTENSIONAHA.118.11465.

9.

HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation.

Tillmann FP, Rump LC, Quack I.

Int Urol Nephrol. 2018 Aug;50(8):1529-1534. doi: 10.1007/s11255-018-1917-7. Epub 2018 Jun 26.

PMID:
29946816
10.

Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms.

Heinrich DA, Adolf C, Rump LC, Quack I, Quinkler M, Hahner S, Januszewicz A, Seufert J, Willenberg HS, Nirschl N, Sturm L, Beuschlein F, Reincke M.

Eur J Endocrinol. 2018 Jun;178(6):605-611. doi: 10.1530/EJE-17-0978. Epub 2018 Apr 10.

PMID:
29636356
11.

Erythrocyte Salt Sedimentation Assay Does Not Predict Response to Renal Denervation.

Vonend O, Martin O, Rump LC, Kroepil P, Stegbauer J.

Front Med (Lausanne). 2018 Mar 9;5:51. doi: 10.3389/fmed.2018.00051. eCollection 2018.

12.

Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice.

Mergia E, Thieme M, Hoch H, Daniil G, Hering L, Yakoub M, Scherbaum CR, Rump LC, Koesling D, Stegbauer J.

Int J Mol Sci. 2018 Mar 23;19(4). pii: E967. doi: 10.3390/ijms19040967.

13.

CLCN2 chloride channel mutations in familial hyperaldosteronism type II.

Scholl UI, Stölting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, Vichot AA, Jin SC, Loring E, Untiet V, Yoo T, Choi J, Xu S, Wu A, Kirchner M, Mertins P, Rump LC, Onder AM, Gamble C, McKenney D, Lash RW, Jones DP, Chune G, Gagliardi P, Choi M, Gordon R, Stowasser M, Fahlke C, Lifton RP.

Nat Genet. 2018 Mar;50(3):349-354. doi: 10.1038/s41588-018-0048-5. Epub 2018 Feb 5.

14.

Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.

Yang G, Istas G, Höges S, Yakoub M, Hendgen-Cotta U, Rassaf T, Rodriguez-Mateos A, Hering L, Grandoch M, Mergia E, Rump LC, Stegbauer J.

Pflugers Arch. 2018 Apr;470(4):661-667. doi: 10.1007/s00424-018-2108-1. Epub 2018 Jan 20.

PMID:
29352340
15.

Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.

Tillmann FP, Schmitz M, Rump LC, Quack I.

Int Urol Nephrol. 2018 Apr;50(4):771-777. doi: 10.1007/s11255-017-1754-0. Epub 2017 Dec 2.

PMID:
29197933
16.

Impact of monocyte-macrophage inhibition by ibandronate on graft function and survival after kidney transplantation: a single-centre follow-up study over 15 years.

Tillmann FP, Grotz W, Rump LC, Pisarski P.

Clin Exp Nephrol. 2018 Apr;22(2):474-480. doi: 10.1007/s10157-017-1470-1. Epub 2017 Aug 30.

PMID:
28856476
17.

Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.

Arns W, Huppertz A, Rath T, Ziefle S, Rump LC, Hansen A, Budde K, Lehner LJ, Shipkova M, Baeumer D, Kroeger I, Sieder C, Klein T, Schenker P.

Transplantation. 2017 Nov;101(11):2780-2788. doi: 10.1097/TP.0000000000001843.

PMID:
28658202
18.

An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.

Rump L, Mattey DL, Kehoe O, Middleton J.

Cytokine. 2017 Sep;97:133-140. doi: 10.1016/j.cyto.2017.05.023.

19.

A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease.

Haase R, Potthoff SA, Meyer-Schwesinger C, Frosch C, Wiech T, Panzer U, Königshausen E, Stegbauer J, Sellin L, Rump LC, Quack I, Woznowski M.

PLoS One. 2017 Jun 12;12(6):e0179217. doi: 10.1371/journal.pone.0179217. eCollection 2017.

20.

Mortality risk factors in intensive care unit patients with acute kidney injury requiring renal replacement therapy: a retrospective cohort study
.

Schmitz M, Tillmann FP, Paluckaite A, Laufer EA, Rayner B, Rump LC, Heering PJ.

Clin Nephrol. 2017 Jul;88(1):27-32. doi: 10.5414/CN109078.

PMID:
28427496
21.

Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up.

Tillmann FP, Radtke A, Rump LC, Quack I.

Exp Clin Transplant. 2017 Dec;15(6):620-626. doi: 10.6002/ect.2016.0196. Epub 2017 Mar 22.

22.

Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.

Thieme M, Sivritas SH, Mergia E, Potthoff SA, Yang G, Hering L, Grave K, Hoch H, Rump LC, Stegbauer J.

Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F474-F481. doi: 10.1152/ajprenal.00376.2016. Epub 2017 Jan 4.

23.

DOAC use in patients with chronic kidney disease.

Kcükköylü S, Rump LC.

Hamostaseologie. 2017;37(4):286-294. doi: 10.5482/HAMO-17-01-0003. Epub 2017 Dec 28. Review.

PMID:
29582930
24.

Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis.

Königshausen E, Zierhut UM, Ruetze M, Potthoff SA, Stegbauer J, Woznowski M, Quack I, Rump LC, Sellin L.

Sci Rep. 2016 Dec 22;6:39513. doi: 10.1038/srep39513.

25.

Evaluation of a Recently Established Test for Familial Hyperaldosteronism Type 1.

Dringenberg T, Sorokina M, Ehlers M, Dekomien G, Haase M, Schulze E, Quinkler M, Rump LC, Schott M, Willenberg HS.

Horm Metab Res. 2016 Dec;48(12):865-868. Epub 2016 Dec 6. No abstract available.

PMID:
27923252
26.

ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.

Yang G, Chu PL, Rump LC, Le TH, Stegbauer J.

Antioxid Redox Signal. 2017 Apr 20;26(12):645-659. doi: 10.1089/ars.2016.6950. Epub 2017 Jan 12. Review.

PMID:
27889958
27.

Role of the receptor Mas in macrophage-mediated inflammation in vivo.

Hammer A, Yang G, Friedrich J, Kovacs A, Lee DH, Grave K, Jörg S, Alenina N, Grosch J, Winkler J, Gold R, Bader M, Manzel A, Rump LC, Müller DN, Linker RA, Stegbauer J.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14109-14114. Epub 2016 Nov 21.

28.

Worsening of lipid metabolism after successful treatment of primary aldosteronism.

Adolf C, Asbach E, Dietz AS, Lang K, Hahner S, Quinkler M, Rump LC, Bidlingmaier M, Treitl M, Ladurner R, Beuschlein F, Reincke M.

Endocrine. 2016 Oct;54(1):198-205. Epub 2016 May 14.

PMID:
27179655
29.

Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.

Potthoff SA, Stamer S, Grave K, Königshausen E, Sivritas SH, Thieme M, Mori Y, Woznowski M, Rump LC, Stegbauer J.

J Renin Angiotensin Aldosterone Syst. 2016 Jul 12;17(3). pii: 1470320316653284. doi: 10.1177/1470320316653284. Print 2016 Jul.

30.

Virulence Gene Profiles and Clonal Relationships of Escherichia coli O26:H11 Isolates from Feedlot Cattle as Determined by Whole-Genome Sequencing.

Gonzalez-Escalona N, Toro M, Rump LV, Cao G, Nagaraja TG, Meng J.

Appl Environ Microbiol. 2016 Jun 13;82(13):3900-3912. doi: 10.1128/AEM.00498-16. Print 2016 Jul 1.

31.

Pulmonary Cytomegalovirus Replication in Renal Transplant Patients with Late Onset Pneumonitis.

Königshausen E, Hengel H, Adams O, Bry H, Steiner S, Priegnitz C, Hansen A, Sellin L, Rump LC, Voiculescu A.

Ann Transplant. 2016 Apr 21;21:235-40.

32.

Prevalence of Malignancies in Patients With Primary Aldosteronism.

Lang K, Weber K, Quinkler M, Dietz AS, Wallaschofski H, Hannemann A, Friedrichs N, Rump LC, Heinze B, Fuss CT, Quack I, Willenberg HS, Reincke M, Allolio B, Hahner S.

J Clin Endocrinol Metab. 2016 Apr;101(4):1656-63. doi: 10.1210/jc.2015-3405. Epub 2016 Feb 4.

PMID:
26844843
33.

Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.

Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, Williams TA, Bornstein SR, Haase M, Rump LC, Willenberg HS, Beuschlein F, Deinum J, Lenders JW, Reincke M.

Clin Chem. 2016 Mar;62(3):514-24. doi: 10.1373/clinchem.2015.251199. Epub 2016 Jan 19.

34.
35.

Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.

Tillmann FP, Schmitz M, Jäger M, Krauspe R, Rump LC.

Int Urol Nephrol. 2016 Feb;48(2):279-86. doi: 10.1007/s11255-015-1133-7. Epub 2015 Oct 26.

PMID:
26498632
36.

Genome Sequences of 64 Non-O157:H7 Shiga Toxin-Producing Escherichia coli Strains.

Toro M, Cao G, Rump L, Nagaraja TG, Meng J, Gonzalez-Escalona N.

Genome Announc. 2015 Oct 1;3(5). pii: e01067-15. doi: 10.1128/genomeA.01067-15.

37.

Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.

Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, Lang K, Quack I, Rump LC, Willenberg HS, Beuschlein F, Quinkler M, Hannemann A; participants of the German Conn's Registry.

Eur J Endocrinol. 2015 Nov;173(5):665-75. doi: 10.1530/EJE-15-0450. Epub 2015 Aug 26.

PMID:
26311088
38.

Simultaneous Presence of Insertion Sequence Excision Enhancer and Insertion Sequence IS629 Correlates with Increased Diversity and Virulence in Shiga Toxin-Producing Escherichia coli.

Toro M, Rump LV, Cao G, Meng J, Brown EW, Gonzalez-Escalona N.

J Clin Microbiol. 2015 Nov;53(11):3466-73. doi: 10.1128/JCM.01349-15. Epub 2015 Aug 19.

39.

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy.

Rump LC, Ammentorp B, Laeis P, Scholze J.

J Clin Hypertens (Greenwich). 2016 Jan;18(1):60-9. doi: 10.1111/jch.12621. Epub 2015 Jul 14.

40.

Virulence characterization of non-O157 Shiga toxin-producing Escherichia coli isolates from food, humans and animals.

Shen J, Rump L, Ju W, Shao J, Zhao S, Brown E, Meng J.

Food Microbiol. 2015 Sep;50:20-7. doi: 10.1016/j.fm.2015.02.007. Epub 2015 Feb 20.

PMID:
25998811
41.

Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Scholl UI, Stölting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP.

Elife. 2015 Apr 24;4:e06315. doi: 10.7554/eLife.06315.

42.

Coronary artery stenosis: a new risk factor for chronic kidney injury?

Rump LC, Stegbauer J.

Kidney Int. 2015 Apr;87(4):676-7. doi: 10.1038/ki.2014.431.

43.

[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology].

Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump LC, Schmieder R, Schulte KL, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F.

Dtsch Med Wochenschr. 2015 Mar;140(5):363. doi: 10.1055/s-0041-100835. Epub 2015 Mar 3. German.

PMID:
25734680
44.

Complete Sequences of Six IncA/C Plasmids of Multidrug-Resistant Salmonella enterica subsp. enterica Serotype Newport.

Cao G, Allard MW, Hoffmann M, Monday SR, Muruvanda T, Luo Y, Payne J, Rump L, Meng K, Zhao S, McDermott PF, Brown EW, Meng J.

Genome Announc. 2015 Feb 26;3(1). pii: e00027-15. doi: 10.1128/genomeA.00027-15.

45.

Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.

Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F.

Clin Res Cardiol. 2015 Aug;104(8):672-8. doi: 10.1007/s00392-015-0832-5. Epub 2015 Feb 26.

PMID:
25715938
46.

Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice.

Suvorava T, Stegbauer J, Thieme M, Pick S, Friedrich S, Rump LC, Hohlfeld T, Kojda G.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):576-583. doi: 10.1016/j.bbrc.2015.01.152. Epub 2015 Feb 11.

PMID:
25680465
47.

Smaller caliber renal arteries are a novel feature of uromodulin-associated kidney disease.

Prejbisz A, Sellin L, Szwench-Pietrasz E, Woznowski M, Michałowska I, Blondin D, Sajnaga D, Epplen JT, Litwin M, Dekomien G, Januszewicz M, Helmchen U, Matuszkiewicz-Rowińska J, Adamczak M, Więcek A, Januszewicz A, Rump LC.

Kidney Int. 2015 Jul;88(1):160-6. doi: 10.1038/ki.2015.2. Epub 2015 Feb 11.

48.

Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.

Wilk CM, Fischer JC, Schieren G, Rox JM, Haas R, Rump LC, Kobbe G, Schroeder T.

Bone Marrow Transplant. 2015 Apr;50(4):613-4. doi: 10.1038/bmt.2014.321. Epub 2015 Jan 26. No abstract available.

PMID:
25621803
49.
50.

[Blood pressure goal and antihypertensive therapy in chronic kidney disease].

Rump LC.

Dtsch Med Wochenschr. 2014 Nov;139(48):2453-7. doi: 10.1055/s-0034-1387416. Epub 2014 Nov 19. Review. German. No abstract available.

PMID:
25409404

Supplemental Content

Support Center